BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Van Limbergen J, Radford-Smith G, Satsangi J. Advances in IBD genetics. Nat Rev Gastroenterol Hepatol. 2014;11:372-385. [PMID: 24614343 DOI: 10.1038/nrgastro.2014.27] [Cited by in Crossref: 94] [Cited by in F6Publishing: 90] [Article Influence: 11.8] [Reference Citation Analysis]
Number Citing Articles
1 Zacharopoulou E, Orfanoudaki E, Tzouvala M, Tribonias G, Kokkotis G, Kitsou V, Almpani F, Christidou A, Viazis N, Mantzaris GJ, Tsafaridou M, Karmiris K, Theodoropoulou A, Papathanasiou E, Zampeli E, Michopoulos S, Tigkas S, Michalopoulos G, Laoudi E, Karatzas P, Mylonas I, Kyriakos N, Liatsos C, Kafetzi T, Theocharis G, Taka S, Panagiotopoulou K, Koutroubakis IE, Bamias G. Patients With Inflammatory Bowel Diseases Have Impaired Antibody Production After Anti-SARS-CoV-2 Vaccination: Results From a Panhellenic Registry. Inflamm Bowel Dis 2022:izac068. [PMID: 35394529 DOI: 10.1093/ibd/izac068] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Yang SK, Ye BD, Song K. ATG16L1 contributes to Crohn's disease susceptibility in Koreans: overmuch concern for ethnic difference? Gut 2015;64:687-8. [PMID: 25200744 DOI: 10.1136/gutjnl-2014-308242] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
3 Coppell KJ, Galts CP, Huizing FY, Norton JK, Gray AR, Schultz K, Hobbs CE, Aluzaite K, Schultz M. Annual Incidence and Phenotypic Presentation of IBD in Southern New Zealand: An 18-Year Epidemiological Analysis. Inflamm Intest Dis 2018;3:32-9. [PMID: 30505840 DOI: 10.1159/000492615] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
4 Aleksandrova K, Romero-Mosquera B, Hernandez V. Diet, Gut Microbiome and Epigenetics: Emerging Links with Inflammatory Bowel Diseases and Prospects for Management and Prevention. Nutrients 2017;9:E962. [PMID: 28867793 DOI: 10.3390/nu9090962] [Cited by in Crossref: 60] [Cited by in F6Publishing: 49] [Article Influence: 12.0] [Reference Citation Analysis]
5 Cao SS. Epithelial ER Stress in Crohn's Disease and Ulcerative Colitis. Inflamm Bowel Dis. 2016;22:984-993. [PMID: 26950312 DOI: 10.1097/mib.0000000000000660] [Cited by in Crossref: 44] [Cited by in F6Publishing: 26] [Article Influence: 7.3] [Reference Citation Analysis]
6 Takahashi S, Yoshimura T, Ohkura T, Fujisawa M, Fushimi S, Ito T, Itakura J, Hiraoka S, Okada H, Yamamoto K, Matsukawa A. A Novel Role of Spred2 in the Colonic Epithelial Cell Homeostasis and Inflammation. Sci Rep 2016;6:37531. [PMID: 27869219 DOI: 10.1038/srep37531] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
7 Andreoletti G, Shakhnovich V, Christenson K, Coelho T, Haggarty R, Afzal NA, Batra A, Petersen BS, Mort M, Beattie RM, Ennis S. Exome Analysis of Rare and Common Variants within the NOD Signaling Pathway. Sci Rep 2017;7:46454. [PMID: 28422189 DOI: 10.1038/srep46454] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
8 Xue X, Ramakrishnan SK, Shah YM. Activation of HIF-1α does not increase intestinal tumorigenesis. Am J Physiol Gastrointest Liver Physiol 2014;307:G187-95. [PMID: 24875099 DOI: 10.1152/ajpgi.00112.2014] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 4.5] [Reference Citation Analysis]
9 Elderman M, van Beek A, Brandsma E, de Haan B, Savelkoul H, de Vos P, Faas M. Sex impacts Th1 cells, Tregs, and DCs in both intestinal and systemic immunity in a mouse strain and location-dependent manner. Biol Sex Differ 2016;7:21. [PMID: 27051505 DOI: 10.1186/s13293-016-0075-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
10 Steegenga WT, Mischke M, Lute C, Boekschoten MV, Pruis MG, Lendvai A, Verkade HJ, Boekhorst J, Timmerman HM, Plösch T, Müller M. Sexually dimorphic characteristics of the small intestine and colon of prepubescent C57BL/6 mice. Biol Sex Differ 2014;5:11. [PMID: 25243059 DOI: 10.1186/s13293-014-0011-9] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 5.4] [Reference Citation Analysis]
11 Däbritz J. GM-CSF and the role of myeloid regulatory cells in the pathogenesis and treatment of Crohn's disease. Mol Cell Pediatr 2015;2:12. [PMID: 26626346 DOI: 10.1186/s40348-015-0024-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
12 Ambrose T, Simmons A. Cannabis, Cannabinoids, and the Endocannabinoid System-Is there Therapeutic Potential for Inflammatory Bowel Disease? J Crohns Colitis 2019;13:525-35. [PMID: 30418525 DOI: 10.1093/ecco-jcc/jjy185] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 9.0] [Reference Citation Analysis]
13 Ahlawat S, Kumar P, Mohan H, Goyal S, Sharma KK. Inflammatory bowel disease: tri-directional relationship between microbiota, immune system and intestinal epithelium. Crit Rev Microbiol 2021;47:254-73. [PMID: 33576711 DOI: 10.1080/1040841X.2021.1876631] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
14 Joshi A, Pooley C, Freeman TC, Lennartsson A, Babina M, Schmidl C, Geijtenbeek T, Michoel T, Severin J, Itoh M, Lassmann T, Kawaji H, Hayashizaki Y, Carninci P, Forrest AR, Rehli M, Hume DA; FANTOM Consortium. Technical Advance: Transcription factor, promoter, and enhancer utilization in human myeloid cells. J Leukoc Biol 2015;97:985-95. [PMID: 25717144 DOI: 10.1189/jlb.6TA1014-477RR] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
15 Hansen R, Russell RK, Muhammed R. Recent advances in paediatric gastroenterology. Arch Dis Child 2015;100:886-90. [DOI: 10.1136/archdischild-2014-307089] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
16 Schwerd T, Pandey S, Yang HT, Bagola K, Jameson E, Jung J, Lachmann RH, Shah N, Patel SY, Booth C, Runz H, Düker G, Bettels R, Rohrbach M, Kugathasan S, Chapel H, Keshav S, Elkadri A, Platt N, Muise AM, Koletzko S, Xavier RJ, Marquardt T, Powrie F, Wraith JE, Gyrd-Hansen M, Platt FM, Uhlig HH. Impaired antibacterial autophagy links granulomatous intestinal inflammation in Niemann-Pick disease type C1 and XIAP deficiency with NOD2 variants in Crohn's disease. Gut 2017;66:1060-73. [PMID: 26953272 DOI: 10.1136/gutjnl-2015-310382] [Cited by in Crossref: 92] [Cited by in F6Publishing: 83] [Article Influence: 18.4] [Reference Citation Analysis]
17 Bąk-Romaniszyn L, Świerzko AS, Sokołowska A, Durko Ł, Mierzwa G, Szala-Poździej A, Małecka-Panas E, Cedzyński M. Mannose-binding lectin (MBL) in adult patients with inflammatory bowel disease. Immunobiology 2020;225:151859. [PMID: 31703823 DOI: 10.1016/j.imbio.2019.10.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
18 Agalioti T, Villablanca EJ, Huber S, Gagliani N. TH17 cell plasticity: The role of dendritic cells and molecular mechanisms. J Autoimmun 2018;87:50-60. [PMID: 29371049 DOI: 10.1016/j.jaut.2017.12.003] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 6.8] [Reference Citation Analysis]
19 Horowitz JE, Warner N, Staples J, Crowley E, Gosalia N, Murchie R, Van Hout C, Fiedler K, Welch G, King AK, Reid JG, Overton JD, Baras A, Shuldiner AR, Griffiths A, Gottesman O, Muise AM, Gonzaga-Jauregui C. Mutation spectrum of NOD2 reveals recessive inheritance as a main driver of Early Onset Crohn's Disease. Sci Rep 2021;11:5595. [PMID: 33692434 DOI: 10.1038/s41598-021-84938-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
20 Mager LF, Koelzer VH, Stuber R, Thoo L, Keller I, Koeck I, Langenegger M, Simillion C, Pfister SP, Faderl M, Genitsch V, Tcymbarevich I, Juillerat P, Li X, Xia Y, Karamitopoulou E, Lyck R, Zlobec I, Hapfelmeier S, Bruggmann R, McCoy KD, Macpherson AJ, Müller C, Beutler B, Krebs P. The ESRP1-GPR137 axis contributes to intestinal pathogenesis. Elife 2017;6:e28366. [PMID: 28975893 DOI: 10.7554/eLife.28366] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
21 Zupančič K, Skok K, Repnik K, Weersma RK, Potočnik U, Skok P. Multi-locus genetic risk score predicts risk for Crohn’s disease in Slovenian population. World J Gastroenterol 2016; 22(14): 3777-3784 [PMID: 27076762 DOI: 10.3748/wjg.v22.i14.3777] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
22 Geem D, Harusato A, Flannigan K, Denning TL. Harnessing regulatory T cells for the treatment of inflammatory bowel disease. Inflamm Bowel Dis. 2015;21:1409-1418. [PMID: 25793328 DOI: 10.1097/mib.0000000000000343] [Cited by in Crossref: 8] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
23 Bramhall M, Flórez-Vargas O, Stevens R, Brass A, Cruickshank S. Quality of methods reporting in animal models of colitis. Inflamm Bowel Dis 2015;21:1248-59. [PMID: 25989337 DOI: 10.1097/MIB.0000000000000369] [Cited by in Crossref: 16] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]
24 Tronstad RR, Polushina T, Brattbakk HR, Stansberg C, von Volkmann HL, Hanevik K, Ellinghaus E, Jørgensen SF, Ersland KM, Pham KD, Gilja OH, Hovdenak N, Hausken T, Vatn MH, Franke A, Knappskog PM, Le Hellard S, Karlsen TH, Fiskerstrand T. Genetic and transcriptional analysis of inflammatory bowel disease-associated pathways in patients with GUCY2C-linked familial diarrhea. Scand J Gastroenterol 2018;53:1264-73. [PMID: 30353760 DOI: 10.1080/00365521.2018.1521867] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
25 Yamamoto-Furusho JK, Fonseca-Camarillo G, Furuzawa-Carballeda J, Sarmiento-Aguilar A, Barreto-Zuñiga R, Martínez-Benitez B, Lara-Velazquez MA. Caspase recruitment domain (CARD) family (CARD9, CARD10, CARD11, CARD14 and CARD15) are increased during active inflammation in patients with inflammatory bowel disease. J Inflamm (Lond) 2018;15:13. [PMID: 30008619 DOI: 10.1186/s12950-018-0189-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
26 Coelho T, Andreoletti G, Ashton JJ, Pengelly RJ, Gao Y, Ramakrishnan A, Batra A, Beattie RM, Williams AP, Ennis S. Immuno-Genomic Profiling of Patients with Inflammatory Bowel Disease: A Systematic Review of Genetic and Functional In Vivo Studies of Implicated Genes. Inflammatory Bowel Diseases 2014;20:1813-9. [DOI: 10.1097/mib.0000000000000174] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
27 Bamias G, Pizarro TT, Cominelli F. Pathway-based approaches to the treatment of inflammatory bowel disease. Transl Res 2016;167:104-15. [PMID: 26408803 DOI: 10.1016/j.trsl.2015.09.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
28 Karthikeyan A, Young KN, Moniruzzaman M, Beyene AM, Do K, Kalaiselvi S, Min T. Curcumin and Its Modified Formulations on Inflammatory Bowel Disease (IBD): The Story So Far and Future Outlook. Pharmaceutics 2021;13:484. [PMID: 33918207 DOI: 10.3390/pharmaceutics13040484] [Reference Citation Analysis]
29 Younis N, Zarif R, Mahfouz R. Inflammatory bowel disease: between genetics and microbiota. Mol Biol Rep 2020;47:3053-63. [PMID: 32086718 DOI: 10.1007/s11033-020-05318-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
30 Ding ZH, Xu XP, Wang TR, Liang X, Ran ZH, Lu H. The prevalence of Helicobacter pylori infection in inflammatory bowel disease in China: A case-control study. PLoS One 2021;16:e0248427. [PMID: 33711050 DOI: 10.1371/journal.pone.0248427] [Reference Citation Analysis]
31 [DOI: 10.1101/098574] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
32 Park SH, Hong M, Lee HS, Ye BD, Hwang SW, Jung S, Baek J, Moon JW, Kim BM, Oh SH, Kim KM, Lee I, Im CN, Liu J, McGovern DPB, Yang SK, Song K. Association of TRAP1 with infliximab-induced mucosal healing in Crohn's disease. J Gastroenterol Hepatol 2019;34:2118-25. [PMID: 31039275 DOI: 10.1111/jgh.14696] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
33 Vindigni SM, Zisman TL, Suskind DL, Damman CJ. The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directions. Therap Adv Gastroenterol. 2016;9:606-625. [PMID: 27366227 DOI: 10.1177/1756283x16644242] [Cited by in Crossref: 89] [Cited by in F6Publishing: 55] [Article Influence: 14.8] [Reference Citation Analysis]
34 Jiang W, Li X. Molecular Analysis of Inflammatory Bowel Disease: Clinically Useful Tools for Diagnosis, Response Prediction, and Monitoring of Targeted Therapy. Mol Diagn Ther 2015;19:141-58. [DOI: 10.1007/s40291-015-0142-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
35 Warner N, Burberry A, Pliakas M, McDonald C, Núñez G. A genome-wide small interfering RNA (siRNA) screen reveals nuclear factor-κB (NF-κB)-independent regulators of NOD2-induced interleukin-8 (IL-8) secretion. J Biol Chem 2014;289:28213-24. [PMID: 25170077 DOI: 10.1074/jbc.M114.574756] [Cited by in Crossref: 32] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
36 Miyoshi J, Bobe AM, Miyoshi S, Huang Y, Hubert N, Delmont TO, Eren AM, Leone V, Chang EB. Peripartum Antibiotics Promote Gut Dysbiosis, Loss of Immune Tolerance, and Inflammatory Bowel Disease in Genetically Prone Offspring. Cell Rep. 2017;20:491-504. [PMID: 28700948 DOI: 10.1016/j.celrep.2017.06.060] [Cited by in Crossref: 58] [Cited by in F6Publishing: 47] [Article Influence: 14.5] [Reference Citation Analysis]
37 Hanyang L, Xuanzhe L, Xuyang C, Yujia Q, Jiarong F, Jun S, Zhihua R. Application of Zebrafish Models in Inflammatory Bowel Disease. Front Immunol 2017;8:501. [PMID: 28515725 DOI: 10.3389/fimmu.2017.00501] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
38 Moon CM, Kim SW, Ahn JB, Ma HW, Che X, Kim TI, Kim WH, Cheon JH. Deep Resequencing of Ulcerative Colitis-Associated Genes Identifies Novel Variants in Candidate Genes in the Korean Population. Inflamm Bowel Dis 2018;24:1706-17. [PMID: 29733354 DOI: 10.1093/ibd/izy122] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
39 Ostrowski J, Paziewska A, Lazowska I, Ambrozkiewicz F, Goryca K, Kulecka M, Rawa T, Karczmarski J, Dabrowska M, Zeber-Lubecka N. Genetic architecture differences between pediatric and adult-onset inflammatory bowel diseases in the Polish population. Sci Rep. 2016;6:39831. [PMID: 28008999 DOI: 10.1038/srep39831] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
40 Lam AJ, Hoeppli RE, Levings MK. Harnessing Advances in T Regulatory Cell Biology for Cellular Therapy in Transplantation. Transplantation 2017;101:2277-87. [PMID: 28376037 DOI: 10.1097/TP.0000000000001757] [Cited by in Crossref: 27] [Cited by in F6Publishing: 15] [Article Influence: 5.4] [Reference Citation Analysis]
41 Manzanillo P, Eidenschenk C, Ouyang W. Deciphering the crosstalk among IL-1 and IL-10 family cytokines in intestinal immunity. Trends Immunol 2015;36:471-8. [PMID: 26184648 DOI: 10.1016/j.it.2015.06.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
42 Martinez-Chamorro A, Moreno A, Gómez-García M, Cabello MJ, Martin J, Lopez-Nevot MÁ. Epistatic interaction between TLR4 and NOD2 in patients with Crohn's Disease: relation with risk and phenotype in a Spanish cohort. Immunobiology 2016;221:927-33. [PMID: 27290609 DOI: 10.1016/j.imbio.2016.05.015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
43 Jain U, Otley AR, Van Limbergen J, Stadnyk AW. The Complement System in Inflammatory Bowel Disease: . Inflammatory Bowel Diseases 2014;20:1628-37. [DOI: 10.1097/mib.0000000000000056] [Cited by in Crossref: 27] [Cited by in F6Publishing: 12] [Article Influence: 3.4] [Reference Citation Analysis]
44 Sheng Y, Li H, Liu M, Xie B, Wei W, Wu J, Meng F, Wang HY, Chen S. A Manganese-Superoxide Dismutase From Thermus thermophilus HB27 Suppresses Inflammatory Responses and Alleviates Experimentally Induced Colitis. Inflamm Bowel Dis 2019;25:1644-55. [PMID: 31067299 DOI: 10.1093/ibd/izz097] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
45 Song L, Chang R, Sun X, Lu L, Gao H, Lu H, Lin R, Xu X, Liu Z, Zhan L. Macrophage-derived EDA-A2 inhibits intestinal stem cells by targeting miR-494/EDA2R/β-catenin signaling in mice. Commun Biol 2021;4:213. [PMID: 33594251 DOI: 10.1038/s42003-021-01730-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
46 Brugman S. The zebrafish as a model to study intestinal inflammation. Dev Comp Immunol 2016;64:82-92. [PMID: 26902932 DOI: 10.1016/j.dci.2016.02.020] [Cited by in Crossref: 127] [Cited by in F6Publishing: 112] [Article Influence: 21.2] [Reference Citation Analysis]
47 de Silva P, Korzenik J. The changing epidemiology of inflammatory bowel disease: identifying new high-risk populations. Clin Gastroenterol Hepatol 2015;13:690-2. [PMID: 25451560 DOI: 10.1016/j.cgh.2014.11.022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
48 Zacharopoulou E, Gazouli M, Tzouvala M, Vezakis A, Karamanolis G. The contribution of long non-coding RNAs in Inflammatory Bowel Diseases. Dig Liver Dis. 2017;49:1067-1072. [PMID: 28869157 DOI: 10.1016/j.dld.2017.08.003] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 6.4] [Reference Citation Analysis]
49 Hirata Y, Ihara S, Koike K. Targeting the complex interactions between microbiota, host epithelial and immune cells in inflammatory bowel disease. Pharmacol Res 2016;113:574-84. [PMID: 27702681 DOI: 10.1016/j.phrs.2016.09.044] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
50 Ferreira IB, Pickering DA, Troy S, Croese J, Loukas A, Navarro S. Suppression of inflammation and tissue damage by a hookworm recombinant protein in experimental colitis. Clin Transl Immunology 2017;6:e157. [PMID: 29114386 DOI: 10.1038/cti.2017.42] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
51 Liefferinckx C, Franchimont D. Viewpoint: Toward the Genetic Architecture of Disease Severity in Inflammatory Bowel Diseases. Inflamm Bowel Dis 2018;24:1428-39. [PMID: 29788122 DOI: 10.1093/ibd/izy109] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
52 Dunn KA, Moore-Connors J, MacIntyre B, Stadnyk AW, Thomas NA, Noble A, Mahdi G, Rashid M, Otley AR, Bielawski JP, Van Limbergen J. Early Changes in Microbial Community Structure Are Associated with Sustained Remission After Nutritional Treatment of Pediatric Crohn's Disease. Inflamm Bowel Dis. 2016;22:2853-2862. [PMID: 27805918 DOI: 10.1097/mib.0000000000000956] [Cited by in Crossref: 41] [Cited by in F6Publishing: 20] [Article Influence: 10.3] [Reference Citation Analysis]
53 Goldner D, Margolis KG. Association of Serotonin Transporter Promoter Polymorphism (5HTTLPR) with Microscopic Colitis and Ulcerative Colitis: Time to Be AsSERTive? Dig Dis Sci 2015;60:819-21. [PMID: 25732715 DOI: 10.1007/s10620-015-3598-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
54 Ananthakrishnan AN. Epidemiology and risk factors for IBD. Nat Rev Gastroenterol Hepatol. 2015;12:205-217. [PMID: 25732745 DOI: 10.1038/nrgastro.2015.34] [Cited by in Crossref: 662] [Cited by in F6Publishing: 604] [Article Influence: 94.6] [Reference Citation Analysis]
55 Moayyedi P. Fecal transplantation: any real hope for inflammatory bowel disease? Curr Opin Gastroenterol 2016;32:282-6. [PMID: 27152872 DOI: 10.1097/MOG.0000000000000285] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
56 Lambert K, Pappas D, Miglioretto C, Javadpour A, Reveley H, Frank L, Grimm MC, Samocha-Bonet D, Hold GL. Systematic review with meta-analysis: dietary intake in adults with inflammatory bowel disease. Aliment Pharmacol Ther 2021;54:742-54. [PMID: 34323292 DOI: 10.1111/apt.16549] [Reference Citation Analysis]
57 Motta JP, Rolland C, Edir A, Florence AC, Sagnat D, Bonnart C, Rousset P, Guiraud L, Quaranta-Nicaise M, Mas E, Bonnet D, Verdu EF, McKay DM, Buscail E, Alric L, Vergnolle N, Deraison C. Epithelial production of elastase is increased in inflammatory bowel disease and causes mucosal inflammation. Mucosal Immunol 2021;14:667-78. [PMID: 33674762 DOI: 10.1038/s41385-021-00375-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
58 Michaels MA, Jendrek ST, Korf T, Nitzsche T, Teegen B, Komorowski L, Derer S, Schröder T, Baer F, Lehnert H, Büning J, Fellerman K, Sina C. Pancreatic Autoantibodies Against CUZD1 and GP2 Are Associated with Distinct Clinical Phenotypes of Crohn's Disease. Inflamm Bowel Dis 2015;21:2864-72. [PMID: 26273818 DOI: 10.1097/MIB.0000000000000564] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
59 Zhang J, Chen L, Xiong F, Zhang S, Huang K, Zhang Z, Wang CY. Autophagy in regulatory T cells: A double-edged sword in disease settings. Mol Immunol 2019;109:43-50. [PMID: 30852245 DOI: 10.1016/j.molimm.2019.02.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
60 Palmieri O, Creanza TM, Bossa F, Latiano T, Corritore G, Palumbo O, Martino G, Biscaglia G, Scimeca D, Carella M, Ancona N, Andriulli A, Latiano A. Functional Implications of MicroRNAs in Crohn's Disease Revealed by Integrating MicroRNA and Messenger RNA Expression Profiling. Int J Mol Sci 2017;18:E1580. [PMID: 28726756 DOI: 10.3390/ijms18071580] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
61 Kabat AM, Harrison OJ, Riffelmacher T, Moghaddam AE, Pearson CF, Laing A, Abeler-Dörner L, Forman SP, Grencis RK, Sattentau Q, Simon AK, Pott J, Maloy KJ. The autophagy gene Atg16l1 differentially regulates Treg and TH2 cells to control intestinal inflammation. Elife 2016;5:e12444. [PMID: 26910010 DOI: 10.7554/eLife.12444] [Cited by in Crossref: 109] [Cited by in F6Publishing: 66] [Article Influence: 18.2] [Reference Citation Analysis]
62 Baillie JK, Arner E, Daub C, De Hoon M, Itoh M, Kawaji H, Lassmann T, Carninci P, Forrest AR, Hayashizaki Y, Faulkner GJ, Wells CA, Rehli M, Pavli P, Summers KM, Hume DA; FANTOM Consortium. Analysis of the human monocyte-derived macrophage transcriptome and response to lipopolysaccharide provides new insights into genetic aetiology of inflammatory bowel disease. PLoS Genet 2017;13:e1006641. [PMID: 28263993 DOI: 10.1371/journal.pgen.1006641] [Cited by in F6Publishing: 49] [Reference Citation Analysis]
63 Kelsen JR, Sullivan KE. Inflammatory Bowel Disease in Primary Immunodeficiencies. Curr Allergy Asthma Rep 2017;17:57. [PMID: 28755025 DOI: 10.1007/s11882-017-0724-z] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
64 Schulberg J, De Cruz P. Characterisation and therapeutic manipulation of the gut microbiome in inflammatory bowel disease: The gut microbiome in IBD. Intern Med J 2016;46:266-73. [DOI: 10.1111/imj.13003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
65 Dunn KA, Moore-connors J, Macintyre B, Stadnyk A, Thomas NA, Noble A, Mahdi G, Rashid M, Otley AR, Bielawski JP, Van Limbergen J. The Gut Microbiome of Pediatric Crohnʼs Disease Patients Differs from Healthy Controls in Genes That Can Influence the Balance Between a Healthy and Dysregulated Immune Response: . Inflammatory Bowel Diseases 2016;22:2607-18. [DOI: 10.1097/mib.0000000000000949] [Cited by in Crossref: 23] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
66 Miyoshi J, Chang EB. The gut microbiota and inflammatory bowel diseases. Transl Res 2017;179:38-48. [PMID: 27371886 DOI: 10.1016/j.trsl.2016.06.002] [Cited by in Crossref: 70] [Cited by in F6Publishing: 67] [Article Influence: 11.7] [Reference Citation Analysis]
67 Selvanantham T, Lin Q, Guo CX, Surendra A, Fieve S, Escalante NK, Guttman DS, Streutker CJ, Robertson SJ, Philpott DJ, Mallevaey T. NKT Cell–Deficient Mice Harbor an Altered Microbiota That Fuels Intestinal Inflammation during Chemically Induced Colitis. J I 2016;197:4464-72. [DOI: 10.4049/jimmunol.1601410] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 8.5] [Reference Citation Analysis]
68 Boyapati R, Satsangi J, Ho GT. Pathogenesis of Crohn's disease. F1000Prime Rep. 2015;7:44. [PMID: 26097717 DOI: 10.12703/p7-44] [Cited by in Crossref: 41] [Cited by in F6Publishing: 22] [Article Influence: 5.9] [Reference Citation Analysis]
69 Tontini GE, Vecchi M, Pastorelli L, Neurath MF, Neumann H. Differential diagnosis in inflammatory bowel disease colitis: State of the art and future perspectives. World J Gastroenterol 2015; 21(1): 21-46 [PMID: 25574078 DOI: 10.3748/wjg.v21.i1.21] [Cited by in CrossRef: 91] [Cited by in F6Publishing: 76] [Article Influence: 13.0] [Reference Citation Analysis]
70 de Bruyn M, Vandooren J, Ugarte-berzal E, Arijs I, Vermeire S, Opdenakker G. The molecular biology of matrix metalloproteinases and tissue inhibitors of metalloproteinases in inflammatory bowel diseases. Critical Reviews in Biochemistry and Molecular Biology 2016;51:295-358. [DOI: 10.1080/10409238.2016.1199535] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 6.3] [Reference Citation Analysis]
71 Spekhorst LM, Visschedijk MC, Weersma RK, Festen EA. Down the line from genome-wide association studies in inflammatory bowel disease: the resulting clinical benefits and the outlook for the future. Expert Review of Clinical Immunology 2014;11:33-44. [DOI: 10.1586/1744666x.2015.990439] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
72 Tsianos VE, Kostoulas C, Gazouli M, Frillingos S, Georgiou I, Christodoulou DK, Katsanos KH, Tsianos EV. ATG16L1 T300A polymorphism is associated with Crohn's disease in a Northwest Greek cohort, but ECM1 T130M and G290S polymorphisms are not associated with ulcerative colitis. Ann Gastroenterol 2020;33:38-44. [PMID: 31892796 DOI: 10.20524/aog.2019.0434] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
73 Thorsen SU, Jakobsen C, Cohen A, Lundqvist M, Thygesen LC, Pipper C, Ascherio A, Svensson J. Perinatal vitamin D levels are not associated with later risk of developing pediatric-onset inflammatory bowel disease: a Danish case-cohort study. Scand J Gastroenterol 2016;51:927-33. [PMID: 26872831 DOI: 10.3109/00365521.2016.1144218] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
74 Padovani BN, Abrantes do Amaral M, Fénero CM, Paredes LC, Boturra de Barros GJ, Xavier IK, Hiyane MI, Ghirotto B, Feijóo CG, Saraiva Câmara NO, Takiishi T. Different wild type strains of zebrafish show divergent susceptibility to TNBS-induced intestinal inflammation displaying distinct immune cell profiles. Current Research in Immunology 2022;3:13-22. [DOI: 10.1016/j.crimmu.2021.12.003] [Reference Citation Analysis]
75 Stern AM, Schurdak ME, Bahar I, Berg JM, Taylor DL. A Perspective on Implementing a Quantitative Systems Pharmacology Platform for Drug Discovery and the Advancement of Personalized Medicine. J Biomol Screen 2016;21:521-34. [PMID: 26962875 DOI: 10.1177/1087057116635818] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 4.5] [Reference Citation Analysis]
76 Bellaguarda E, Chang EB. IBD and the gut microbiota--from bench to personalized medicine. Curr Gastroenterol Rep 2015;17:15. [PMID: 25762474 DOI: 10.1007/s11894-015-0439-z] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 5.9] [Reference Citation Analysis]
77 Kabat AM, Pott J, Maloy KJ. The Mucosal Immune System and Its Regulation by Autophagy. Front Immunol 2016;7:240. [PMID: 27446072 DOI: 10.3389/fimmu.2016.00240] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 7.7] [Reference Citation Analysis]
78 Castaño-Rodríguez N, Kaakoush NO, Lee WS, Mitchell HM. Dual role of Helicobacter and Campylobacter species in IBD: a systematic review and meta-analysis. Gut 2017;66:235-49. [PMID: 26508508 DOI: 10.1136/gutjnl-2015-310545] [Cited by in Crossref: 119] [Cited by in F6Publishing: 109] [Article Influence: 23.8] [Reference Citation Analysis]
79 Mirza AH, Berthelsen CH, Seemann SE, Pan X, Frederiksen KS, Vilien M, Gorodkin J, Pociot F. Transcriptomic landscape of lncRNAs in inflammatory bowel disease. Genome Med. 2015;7:39. [PMID: 25991924 DOI: 10.1186/s13073-015-0162-2] [Cited by in Crossref: 97] [Cited by in F6Publishing: 98] [Article Influence: 13.9] [Reference Citation Analysis]
80 Vignal C, Desreumaux P, Body-malapel M. Gut: An underestimated target organ for Aluminum. Morphologie 2016;100:75-84. [DOI: 10.1016/j.morpho.2016.01.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
81 Khan F, Radovanovic A, Gojobori T, Kaur M. IBDDB: a manually curated and text-mining-enhanced database of genes involved in inflammatory bowel disease. Database (Oxford) 2021;2021:baab022. [PMID: 33929018 DOI: 10.1093/database/baab022] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
82 Cao SS. Endoplasmic reticulum stress and unfolded protein response in inflammatory bowel disease. Inflamm Bowel Dis. 2015;21:636-644. [PMID: 25581827 DOI: 10.1097/mib.0000000000000238] [Cited by in Crossref: 34] [Cited by in F6Publishing: 21] [Article Influence: 4.9] [Reference Citation Analysis]
83 Wang S, Hou Y, Chen W, Wang J, Xie W, Zhang X, Zeng L. KIF9‑AS1, LINC01272 and DIO3OS lncRNAs as novel biomarkers for inflammatory bowel disease. Mol Med Rep 2018;17:2195-202. [PMID: 29207070 DOI: 10.3892/mmr.2017.8118] [Cited by in Crossref: 6] [Cited by in F6Publishing: 21] [Article Influence: 1.2] [Reference Citation Analysis]
84 Paulus GL, Xavier RJ. Autophagy and checkpoints for intracellular pathogen defense. Curr Opin Gastroenterol 2015;31:14-23. [PMID: 25394238 DOI: 10.1097/MOG.0000000000000134] [Cited by in Crossref: 28] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
85 Fitzgerald RS, Sanderson IR, Claesson MJ. Paediatric Inflammatory Bowel Disease and its Relationship with the Microbiome. Microb Ecol 2021. [PMID: 33666710 DOI: 10.1007/s00248-021-01697-9] [Reference Citation Analysis]
86 Jeong EM, Son YH, Choi Y, Kim JH, Lee JH, Cho SY, Kim IG. Transglutaminase 2 is dispensable but required for the survival of mice in dextran sulfate sodium-induced colitis. Exp Mol Med 2016;48:e267. [PMID: 27811936 DOI: 10.1038/emm.2016.95] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
87 Endale M, Aksoylar HI, Hoebe K. Central role of gimap5 in maintaining peripheral tolerance and T cell homeostasis in the gut. Mediators Inflamm 2015;2015:436017. [PMID: 25944983 DOI: 10.1155/2015/436017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
88 Cardoso A, Gil Castro A, Martins AC, Carriche GM, Murigneux V, Castro I, Cumano A, Vieira P, Saraiva M. The Dynamics of Interleukin-10-Afforded Protection during Dextran Sulfate Sodium-Induced Colitis. Front Immunol 2018;9:400. [PMID: 29545807 DOI: 10.3389/fimmu.2018.00400] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
89 Zabana Y, Lorén V, Domènech E, Aterido A, Garcia-Jaraquemada A, Julià A, Vicario M, Pedrosa E, Ferreiro M, Troya J, Lozano JJ, Sarrias MR, Cabré E, Mañosa M, Manyé J. Transcriptomic identification of TMIGD1 and its relationship with the ileal epithelial cell differentiation in Crohn's disease. Am J Physiol Gastrointest Liver Physiol 2020;319:G109-20. [PMID: 32508154 DOI: 10.1152/ajpgi.00027.2020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
90 Moura FA, Goulart MOF. Inflammatory Bowel Diseases. Gastrointestinal Tissue. Elsevier; 2017. pp. 99-112. [DOI: 10.1016/b978-0-12-805377-5.00007-2] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
91 Oh SH, Kim KM. Current issues of pediatric inflammatory bowel disease in Korea. Korean J Pediatr. 2014;57:465-471. [PMID: 25550700 DOI: 10.3345/kjp.2014.57.11.465] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
92 Uhlig HH, Schwerd T. From Genes to Mechanisms: The Expanding Spectrum of Monogenic Disorders Associated with Inflammatory Bowel Disease. Inflamm Bowel Dis 2016;22:202-12. [PMID: 26512716 DOI: 10.1097/MIB.0000000000000614] [Cited by in Crossref: 44] [Cited by in F6Publishing: 24] [Article Influence: 7.3] [Reference Citation Analysis]